Accessibility Menu
 

Ir Biosciences

(OTC) IRBS

Current PriceN/A
Market CapN/A
Since IPO (2003)-100%
5 Year+0%
1 Year+0%
1 Month+0%

Ir Biosciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$5.28M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

IRBS News

No articles available.

IRBS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ir Biosciences

Industry

Biotechnology

Headquarters

Scottsdale, US

IRBS Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

47%

Return on Capital

44%

Return on Assets

-80%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$2.86M

EBITDA

$3.57M

Operating Cash Flow

$430.31K

Capital Expenditure

$1.00

Free Cash Flow

$430.31K

Cash & ST Invst.

$0.00

Total Debt

$3.64M

Ir Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2010YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

4

N/A

Net Income

$343.00K

-146.9%

EBITDA

$140.46K

-89.4%

Quarterly Fundamentals

Name
Q4 2010YOY CHG

Net Cash

$3.64M

+37.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$3.64M

+81.9%

Return on Assets

-80.22%

N/A

Return on Invested Capital

44.40%

N/A

Free Cash Flow

$150.00K

+70.4%

Operating Cash Flow

$150.00K

+70.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSTCGlobeStar Therapeutics Corporation
$0.00+0.00%
GBLXGB Sciences, Inc.
$0.00+50.00%
RGMPRegnum Corp.
$0.00+0.00%
SCPXScorpius Holdings, Inc.
$0.01-0.79%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About IRBS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.